Products
15180 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nokia Constant Leverage with ISIN code: CH1450969097 | Nokia | Constant Leverage | Short | ― | 5.563 | 0.072 | 0.001 | 0.073 | 1 | -7.69% | -6.49% | -48.57% | 21 Aug. 2025 | |
| Nokia Constant Leverage with ISIN code: CH1235293169 | Nokia | Constant Leverage | Short | ― | 5.563 | 0.087 | 0.001 | 0.088 | 1 | -5.43% | -4.40% | -33.08% | 30 Nov. 2022 | |
| Novartis Constant Leverage with ISIN code: CH1423416671 | Novartis | Constant Leverage | Long | ― | 109.889 | 18.12 | 0.140 | 18.26 | 1 | 3.13% | 15.71% | 54.34% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587271 | Novartis | Constant Leverage | Long | ― | 109.889 | 12.71 | 0.040 | 12.75 | 1 | 1.03% | 5.13% | 17.58% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587305 | Novartis | Constant Leverage | Long | ― | 109.889 | 1.17 | 0.010 | 1.18 | 1 | 2.63% | 11.43% | 42.68% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587289 | Novartis | Constant Leverage | Long | ― | 109.889 | 8.59 | 0.030 | 8.62 | 1 | 1.54% | 7.91% | 26.70% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587297 | Novartis | Constant Leverage | Long | ― | 109.889 | 3.97 | 0.020 | 3.99 | 1 | 2.32% | 10.28% | 35.96% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587255 | Novartis | Constant Leverage | Short | ― | 109.889 | 0.31 | 0.010 | 0.32 | 1 | 0.00% | -13.89% | -31.11% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 109.889 | 1.31 | 0.010 | 1.32 | 1 | -0.76% | -7.09% | -19.63% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 109.889 | 0.18 | 0.010 | 0.19 | 1 | 0.00% | -25.00% | -51.35% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 109.889 | 0.062 | 0.001 | 0.063 | 1 | 0.00% | -12.68% | -32.61% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 109.889 | 0.42 | 0.010 | 0.43 | 1 | -2.33% | -17.65% | -44.00% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 327.136 | 0.13 | 0.010 | 0.14 | 1 | -13.33% | 54.76% | -13.33% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 327.136 | 0.01 | ― | ― | 1 | 11.11% | 11.11% | 11.11% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 327.136 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 327.136 | 2.83 | 0.020 | 2.85 | 1 | -7.21% | 36.71% | -2.75% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 327.136 | 6.18 | 0.030 | 6.21 | 1 | -4.92% | 25.87% | 2.66% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 327.136 | 5.31 | 0.020 | 5.33 | 1 | 3.51% | -33.04% | -26.86% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 327.136 | 0.3 | 0.010 | 0.31 | 1 | -3.23% | -51.61% | -47.37% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 327.136 | 0.04 | 0.001 | 0.041 | 1 | 2.56% | -85.71% | -84.62% | 7 May. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.